The science is clear: extra weight is not just from lifestyle choices. It is often a complex, long-term health issue. This condition needs a personalised, medically-informed approach. This means that people with obesity or who have trouble losing weight are not lacking motivation or discipline. Instead, their biological systems that control hunger, fullness, and energy storage may be making it harder for them.
In light of this, modern medicine has shifted its focus toward targeted therapies that support the body’s natural regulatory systems. And among the most promising of these advancements are a new class of medications are weight loss injections that have demonstrated clinically significant results.
Weight Loss Injections at The Health Suite Leicester
If you are looking for weight loss injections in Leicester, it’s time to see how these treatments can help you. The expert team at The Health Suite can guide you through the process. At The Health Suite, we’re committed to evidence-based medicine and new ways to manage weight. Our team continually evaluates the latest clinical research to ensure our patients have access to the most effective, science-backed treatments available. We are proud to provide the best weight loss injections, including Wegovy, Ozempic, and Mounjaro. Our experienced GP team in Leicester prescribes and carefully monitors each treatment. Our medical professionals conduct thorough consultations to assess suitability for treatment and ensure that weight loss injections are a safe and effective option for each patient.
Learn more about the weight loss injections at The Health Suite Leicester
Are You Eligible for Weight Loss Injections?
Weight loss injections might be a good treatment choice for people who meet one or more of these criteria:
- Have a Body Mass Index (BMI) of 30 or higher, which is classified as obesity.
- If you have a BMI of 27 or higher, you may have a weight-related health issue. This can include type 2 diabetes, high blood pressure, or obstructive sleep apnea.
- Have experienced difficulty losing weight or maintaining weight loss despite sustained efforts with diet and exercise.
- You would benefit from clinical support to safely reach and maintain a healthier weight with a medical professional’s help.
Understanding the Leading Weight Loss Injections
Wegovy (semaglutide): Wegovy is a once-weekly injectable medication containing semaglutide. Semaglutide is a type of peptide. A peptide is a short chain of amino acids, which are small proteins. It acts as a messenger in the body.
How weight-loss injections work:
When we eat, our bodies naturally release a hormone called GLP-1 (glucagon-like peptide-1) from the gut. This hormone plays a crucial role in regulating appetite, digestion, and blood sugar levels. It sends signals to the brain that make you feel full. It also slows how fast the stomach empties. This helps the pancreas release insulin and lowers the hormone glucagon, which raises blood sugar. Wegovy works by mimicking this natural hormone. It enhances the body’s own GLP-1 response, helping to regulate appetite more effectively and improve metabolic control. The result is a greater sense of satiety (feeling full), fewer hunger signals, and a reduced desire to eat, all without the need for willpower-driven restriction.
Don’t be put off by the scientific language – this process is simpler than it sounds…
By slowing stomach emptying and stabilising blood sugar levels, it also supports longer-lasting energy and fewer cravings between meals.
Wegovy essentially helps your body respond to food in a more balanced and efficient way, which can make a significant difference for those who have struggled with weight due to biological drivers like intense hunger or difficulty feeling full. Semaglutide, the active ingredient in Wegovy, was first made to treat type 2 diabetes. It is now approved for long-term weight management. This is for people with obesity or those who are overweight. They must have at least one weight-related condition, like high blood pressure, type 2 diabetes, or high cholesterol.
Ozempic (semaglutide): Ozempic also contains the same active ingredient as Wegovy – semaglutide – but is licensed primarily for the treatment of type 2 diabetes. While its approved use focuses on improving blood sugar control, it has also been shown to support weight loss by influencing the same biological pathways.
Mounjaro (tirzepatide): Mounjaro is one of the most exciting advances in medical weight management to date. Originally developed to treat type 2 diabetes, it has rapidly gained attention for its powerful effects on weight loss, thanks to its unique way of working through two key hormonal pathways in the body. The active ingredient, tirzepatide, is different from semaglutide, which is in Wegovy and Ozempic. It targets two gut hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
Eating triggers the release of these hormones, which play an important role in managing blood sugar, digestion, and appetite. While GLP-1 therapies like Wegovy and Ozempic work well on their own, Mounjaro’s dual-action approach has been shown in clinical trials to deliver even greater weight loss results and broader metabolic benefits.
How it works: When we eat, GLP-1 and GIP signal the brain to help control appetite, slow down the emptying of the stomach, and support healthy insulin production. Mounjaro mimics both of these hormones, amplifying the body’s natural responses. This results in reduced hunger, increased feelings of fullness, improved insulin sensitivity, and a stronger sense of control over eating. Many patients using Mounjaro report more pronounced appetite suppression and faster weight loss than with GLP-1-only treatments like Wegovy and Ozempic – making it a particularly valuable option for those who have struggled with persistent weight gain, insulin resistance, or limited success from other medications. As with all treatments offered at The Health Suite, Mounjaro is prescribed as part of a carefully monitored, medically-led plan to ensure safety, suitability, and sustainable results.
Learn more about the weight loss injections at The Health Suite Leicester
Benefits of Medical Weight Loss Injections
The weightloss injections we offer here at The Health Suite in Leicester such as Wegovy, Ozempic, and Mounjaro offer a range of clinically proven benefits that go beyond what diet and exercise alone can often achieve. When prescribed and monitored by our healthcare professionals, these treatments can support safe, effective, and sustainable weight management, particularly for individuals facing obesity or related health challenges.
Key benefits include:
- Appetite Regulation & Reduced Cravings: These medications help calm the body’s hunger signals, making it easier to feel full sooner and avoid overeating, without relying solely on willpower.
- Clinically Supported, Sustainable Weight Loss: Unlike rapid or restrictive diets, weight loss injections promote steady, long-term results by working with your body’s natural metabolic pathways.
- Enhanced Fat Metabolism: By improving how the body processes and stores energy, these treatments can support more efficient fat burning and better weight distribution over time.
- Improved Blood Sugar Control: Originally designed to treat type 2 diabetes, these medications also help regulate insulin and glucose levels – this can reduce the risk of blood sugar spikes and improve metabolic health.
- Greater Confidence and Overall Well-being: Achieving a healthier weight often leads to improved energy levels, mood, mobility, and self-esteem, supporting both physical and emotional health.
Medically Supervised Weight Loss Injections in Leicester at The Health Suite
Losing weight is rarely a one-size-fits-all journey, and we know that here at The Health Suite. For many, even the most dedicated efforts with diet and exercise aren’t enough to overcome the complex biological, hormonal, and metabolic factors that contribute to weight gain. That’s where science-led solutions shine through.
What to Expect at The Health Suite
As a trusted private GP service in Leicester, we offer a fully personalised approach to medical weight loss:
- Initial Consultation: Our clinicians take time to understand your medical history, lifestyle, and weight concerns. We’ll assess whether weight loss injections are suitable for you and explain the options in detail.
- Bespoke Treatment Plan: If you qualify, we will create a treatment plan just for you. We will use the best medication, like Wegovy, Ozempic, Mounjaro, or Saxenda. Dosage and frequency will depend on your clinical needs.
- Ongoing Monitoring & Support: Regular follow-ups allow us to monitor your progress, adjust treatment if needed, and provide encouragement throughout your journey. Our team is here for you at every stage.
- Lifestyle & Nutritional Guidance: To get the best results, we combine your treatment with expert advice. This includes diet, exercise, and lifestyle changes. We help you not only lose weight but also keep it off.
Take the Next Step with The Health Suite Leicester
If you’re ready to explore a science-backed approach to lasting weight loss, The Health Suite Leicester is here to help. As a leading provider of weight loss injections in Leicester, we offer personalised care in a discreet, supportive clinical setting.
Book your consultation today to learn more about Wegovy, Ozempic, or Mounjaro and discover whether this innovative treatment is right for you.
Scientific/Academic References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., … & Kelly, A. S. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
- Nauck, M. A., & Meier, J. J. (2019). Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism, 21(S1), 5–21. https://doi.org/10.1111/dom.13610
- Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121), 840–846. https://doi.org/10.1038/nature05482
- Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017). The new biology and pharmacology of glucagon. Physiological Reviews, 97(2), 721–766. https://doi.org/10.1152/physrev.00025.2016
- Drucker, D. J. (2018). Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism, 27(4), 740–756. https://doi.org/10.1016/j.cmet.2018.03.001
- Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E., … & Rossner, S. (2012). Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity, 36(6), 843–854. https://doi.org/10.1038/ijo.2011.158
- Van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. (2014). Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite, and energy metabolism in obese, non-diabetic adults. International Journal of Obesity, 38(6), 784–793. https://doi.org/10.1038/ijo.2013.162
- Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., … & Rubino, D. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831
- Mehta, A., Marso, S. P., & Neeland, I. J. (2017). Liraglutide for weight management: A critical review of the evidence. Obesity Science & Practice, 3(1), 3–14. https://doi.org/10.1002/osp4.84